Advertisement
New Zealand Markets closed
  • NZX 50

    11,755.17
    +8.59 (+0.07%)
     
  • NZD/USD

    0.6023
    -0.0011 (-0.1806%)
     
  • NZD/EUR

    0.5583
    -0.0011 (-0.20%)
     
  • ALL ORDS

    8,022.70
    +28.50 (+0.36%)
     
  • ASX 200

    7,749.00
    +27.40 (+0.35%)
     
  • OIL

    79.81
    +0.55 (+0.69%)
     
  • GOLD

    2,374.50
    +34.20 (+1.46%)
     
  • NASDAQ

    18,113.46
    +28.46 (+0.16%)
     
  • FTSE

    8,428.80
    +47.45 (+0.57%)
     
  • Dow Jones

    39,387.76
    +331.36 (+0.85%)
     
  • DAX

    18,796.46
    +109.86 (+0.59%)
     
  • Hang Seng

    18,962.86
    +425.05 (+2.29%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • NZD/JPY

    93.7000
    -0.0680 (-0.07%)
     

Is This the Telltale Sign to Sell Novavax Stock?

Is This the Telltale Sign to Sell Novavax Stock?

Unfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine, Nuvaxovid. If you only looked at Novavax's press releases, you wouldn't know about some recent bad news for the company.